March Madness — 25% Off — Limited Time
Get All the Market Moving News, Squawk, and Mentorship NOW
get this deal
Deutsch
Español
India
Italiano
Français
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
March Madness — 25% Off — Limited Time
Get All the Market Moving News, Squawk, and Mentorship NOW
get this deal
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
Deutsch
Español
India
Italiano
Français
Sign in
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Sports
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Sports
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Applied DNA Sciences
(NASDAQ:APDN)
Intraday
$0.42
-0.008
[-1.87%]
After-Hours
$0.42
0
[0.00%]
Get Report
Watch
Perks
Buy
Compare Brokers
$0.42
-0.008
[-1.87%]
At close: Mar 28
$0.42
0
[0.00%]
After Hours: 5:34PM EDT
Get Report
Watch
Overview
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest News for Applied DNA Sciences Stock (NASDAQ:APDN)
Applied DNA Sciences Stock (NASDAQ: APDN)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Wednesday, March 20, 2024
12 Health Care Stocks Moving In Wednesday's After-Market Session
Benzinga Insights
-
Mar 20, 2024, 5:34PM
Monday, March 18, 2024
12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga Insights
-
Mar 18, 2024, 9:05AM
Friday, February 09, 2024
HC Wainwright & Co. Maintains Buy on Applied DNA Sciences, Adjusts Price Target To $1.5
Benzinga Newsdesk
-
Feb 9, 2024, 1:27PM
Thursday, February 08, 2024
Recap: Applied DNA Sciences Q1 Earnings
Benzinga Insights
-
Feb 8, 2024, 4:40PM
Applied DNA Sciences Q1 2024 GAAP EPS $(0.09) Beats $(0.31) Estimate, Sales $891.16K Beat $776.00K Estimate
Benzinga Newsdesk
-
Feb 8, 2024, 4:38PM
Earnings Scheduled For February 8, 2024
Benzinga Insights
-
Feb 8, 2024, 4:43AM
Wednesday, February 07, 2024
Earnings Preview For Applied DNA Sciences
Benzinga Insights
-
Feb 7, 2024, 3:01PM
Monday, February 05, 2024
12 Health Care Stocks Moving In Monday's After-Market Session
Benzinga Insights
-
Feb 5, 2024, 4:31PM
Wednesday, January 31, 2024
Applied DNA Announces $3.44M Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
Benzinga Newsdesk
-
Jan 31, 2024, 8:06AM
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga Insights
-
Jan 31, 2024, 8:05AM
Applied DNA Sciences Said Effective January 30, 2024, Terminated The Equity Distribution Agreement With Maxim Group
Charles Gross
-
Jan 31, 2024, 6:13AM
Monday, December 18, 2023
12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga Insights
-
Dec 18, 2023, 8:08AM
Thursday, December 14, 2023
Applied DNA Announces Joint Development Agreement To Integrate Linea IVT Platform Into CDMO Kudo Biotechnology's mRNA Manufacturing Workflow
Benzinga Newsdesk
-
Dec 14, 2023, 8:09AM
Friday, December 08, 2023
Lululemon To Rally Around 14%? Here Are 10 Top Analyst Forecasts For Friday
Avi Kapoor
-
Dec 8, 2023, 7:20AM
HC Wainwright & Co. Maintains Buy on Applied DNA Sciences, Lowers Price Target to $2
Benzinga Newsdesk
-
Dec 8, 2023, 6:58AM
Thursday, December 07, 2023
Applied DNA Sciences: Q4 Earnings Insights
Benzinga Insights
-
Dec 7, 2023, 4:30PM
Applied DNA Sciences Q4 EPS $(0.26) Down From $(0.06) YoY, Sales $779.74K Down From $3.56M YoY
Benzinga Newsdesk
-
Dec 7, 2023, 4:10PM
Earnings Scheduled For December 7, 2023
Benzinga Insights
-
Dec 7, 2023, 5:27AM
Wednesday, December 06, 2023
12 Health Care Stocks Moving In Wednesday's After-Market Session
Benzinga Insights
-
Dec 6, 2023, 4:31PM
Tuesday, November 28, 2023
Applied DNA Announces Receipt Of Linea DNA Follow-On Order For Cancer Diagnostic Application Valued Above Mid-Six Figures; Deliveries Expected During Fiscal Quarter Ending March 31, 2024 Through Dec. 31, 2024
Benzinga Newsdesk
-
Nov 28, 2023, 8:35AM
Thursday, November 16, 2023
Applied DNA Extends Application Of Linea IVT Platform To saRNA
Benzinga Newsdesk
-
Nov 16, 2023, 8:36AM
Thursday, November 09, 2023
Applied DNA Ships First saRNA IVT Template Generated By Linea DNA Platform
Benzinga Newsdesk
-
Nov 9, 2023, 9:29AM
Thursday, September 28, 2023
Applied DNA Sciences Filed U.S. Patent Application #20230304083: "Methods and Systems of Producing Single Stranded DNA via PCR Using Biotin-Labeled Primers"
Charles Gross
-
Sep 28, 2023, 11:51AM
Thursday, September 14, 2023
Applied DNA Partners With Cornell University College Of Veterinary Medicine To Accelerate Development Of Veterinary Vaccine Platform Targeting Diseases That Impact High-Value Animals
Benzinga Newsdesk
-
Sep 14, 2023, 9:17AM
Wednesday, September 06, 2023
Applied DNA Advances Commercialization Of Linea IVT Platform, Appoints Beverly Wolgast As Executive Director Of Quality And cGMP Programs
Happy Mohamed
-
Sep 6, 2023, 9:20AM
Tuesday, August 29, 2023
Applied DNA Announces Availability And First Customer Shipment Of New Linea IVT Evaluation Kit
Happy Mohamed
-
Aug 29, 2023, 9:06AM
Thursday, August 24, 2023
HC Wainwright & Co. Reiterates Buy on Applied DNA Sciences, Maintains $4 Price Target
Benzinga Newsdesk
-
Aug 24, 2023, 6:23AM
Monday, August 14, 2023
HC Wainwright & Co. Maintains Buy on Applied DNA Sciences, Lowers Price Target to $4
Benzinga Newsdesk
-
Aug 14, 2023, 6:43AM
Thursday, August 10, 2023
Applied DNA Sciences Q3 EPS $(0.24), Inline, Sales $2.92M Beat $2.56M Estimate
Benzinga Newsdesk
-
Aug 10, 2023, 4:11PM
Earnings Scheduled For August 10, 2023
Benzinga Insights
-
Aug 10, 2023, 6:59AM
Wednesday, August 09, 2023
Earnings Preview: Applied DNA Sciences
Benzinga Insights
-
Aug 9, 2023, 2:01PM
Friday, July 14, 2023
HC Wainwright & Co. Reiterates Buy on Applied DNA Sciences, Maintains $5 Price Target
Benzinga Newsdesk
-
Jul 14, 2023, 6:15AM
Thursday, July 13, 2023
12 Health Care Stocks Moving In Thursday's Intraday Session
Benzinga Insights
-
Jul 13, 2023, 1:37PM
Applied DNA shares are trading higher after the company announced the acquisition of Spindle Biotech.
Benzinga Newsdesk
-
Jul 13, 2023, 12:28PM
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga Insights
-
Jul 13, 2023, 9:12AM
Market-Moving News for July 13th
Benzinga Newsdesk
-
Jul 13, 2023, 8:44AM
Applied DNA Acquires RNA Polymerase Developer Spindle Biotech For $0.6M Cash, 0.8M Restricted Shares And Earnout; Launches LineaIVT Platform To Substantially Improve mRNA Manufacturing And Broaden Market Reach
Benzinga Newsdesk
-
Jul 13, 2023, 7:21AM
Tuesday, May 30, 2023
Applied DNA Sciences Files For Mixed Shelf Of Up To $75M
Benzinga Newsdesk
-
May 30, 2023, 4:03PM
Friday, May 12, 2023
HC Wainwright & Co. Reiterates Buy on Applied DNA Sciences, Maintains $5 Price Target
Benzinga Newsdesk
-
May 12, 2023, 7:06AM
Thursday, May 11, 2023
Applied DNA Sciences: Q2 Earnings Insights
Benzinga Insights
-
May 11, 2023, 4:50PM
Applied DNA Sciences Q2 EPS $0.05 Beats $(0.20) Estimate, Sales $4.40M Beat $4.12M Estimate
Benzinga Newsdesk
-
May 11, 2023, 4:08PM
Earnings Scheduled For May 11, 2023
Benzinga Insights
-
May 11, 2023, 9:58AM
Monday, May 08, 2023
HC Wainwright & Co. Reiterates Buy on Applied DNA Sciences, Maintains $5 Price Target
Benzinga Newsdesk
-
May 8, 2023, 6:26AM
Friday, May 05, 2023
Applied DNA Sciences Says On May 1, 2023 Co.'s Unit Applied DNA Clinical Labs Received Notice Of Termination From City University Of New York
Benzinga Newsdesk
-
May 5, 2023, 4:07PM
Thursday, March 30, 2023
HC Wainwright & Co. Reiterates Buy on Applied DNA Sciences, Maintains $5 Price Target
Benzinga Newsdesk
-
Mar 30, 2023, 6:28AM
Wednesday, March 29, 2023
Applied DNA Achieves Milestone For Large-Scale linearDNA Production, Delivers Largest Single Shipment By Volume To Date
Happy Mohamed
-
Mar 29, 2023, 9:02AM
Thursday, March 23, 2023
HC Wainwright & Co. Reiterates Buy on Applied DNA Sciences, Maintains $5 Price Target
Benzinga Newsdesk
-
Mar 23, 2023, 6:32AM
Wednesday, March 22, 2023
Applied DNA Submits Validation Package To New York State Department Of Health For Approval Of Pharmacogenomic Assay
Happy Mohamed
-
Mar 22, 2023, 9:44AM
Monday, February 13, 2023
Applied DNA Sciences's Return On Capital Employed Insights
Benzinga Insights
-
Feb 13, 2023, 9:47AM
Friday, February 10, 2023
HC Wainwright & Co. Reiterates Buy on Applied DNA Sciences, Maintains $5 Price Target
Benzinga Newsdesk
-
Feb 10, 2023, 12:06PM
Show more
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch